Mexican HIV Clinical Forum 2018 – Integrase Inhibitors

 

Thursday 13 September

 Session 1
 HIV integrase Inhibitors: A novel mechanisms of action
Francisco Flores Murrieta, PhD - Instituto Politécnico Nacional, Mexico City, Mexico
 
 Schapiro Photo 2008Resistance Characteristics of the Integrase Inhibitors
Jonathan Schapiro, MD - Sheba Medical Center, Ramat Ghan, Israel
(Not yet available)
 
 Clinical case presentation
Aurelio Orta, MD - Instituto Nacional De Ciencias Medicas Y Nutricion Salvador Zubiran, Mexico City, Mexico
 
  Session 2
 Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors
Courtney Fletcher, PharmD - University of Nebraska, Omaha, USA
 
 Clinical Update on Integrase Inhibitors: Recent Data
Pablo Tebas, MD - University of Pennsylvania, Philadelphia, USA
 
 Clinical case presentation
Mauro Schechter, MD, PhD - Universidade Federal do Rio De Janeiro, Rio de Janeiro, Brazil
 
 Clinical case presentation
Samuel Navarro, MD - General Hospital Tijuana, Tijuana, Mexico
 
 Session 3
 Optimal use of Integrase Inhibitors in Routine Patient Care in Mexico
Luis Soto-Ramirez, MD - Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico
 
 Integrase Inhibitors in Women and Pediatrics
Alberto Chaparro-Sánchez, MD - Imss Hospital Infectologia La Raza, Mexico City, Mexico
 
 Clinical case presentation
Santiago Pérez Patrigeon, PhD - Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico